The sulfhydryl alkylating reagent N-ethylmaleimide (NEM) blocks opioid rece
ptor binding and receptor/G-protein coupling. Sodium partially restores [H-
3]naloxone binding after inhibition by NEM to reveal sodium-dependent [H-3]
naloxone sites, defined as binding in the presence of 50-100 mM NaCl after
treatment of membranes or sections with 750 mu m NEM. In the present study,
receptor autoradiography of [H-3]nalaxone binding in control and NEM-treat
ed tissue was used to examine the anatomical distribution of sodium-depende
nt [H-3]naloxone sites in rat brain. In brain membranes, the pharmacology o
f sodium-dependent [H-3] naloxone sites was consistent with that of mu opio
id receptors. Relatively high IC50 values for agonists and lack of effect o
f Gpp(NH)p on DAMGO displacement of [H-3]naloxone binding in NEM-treated me
mbranes indicated that the sodium-dependent sites were low affinity sites,
presumably uncoupled from G-proteins. Autoradiograms revealed that NEM trea
tment dramatically reduced [H-3]naloxone binding in all brain regions. Howe
ver, [H-3]naloxone binding was increased in specific regions in NEM-treated
sections in the presence of sodium, including bed nucleus of the stria ter
minalis, interpeduncular nucleus, periaqueductal gray, parabrachial nucleus
, locus coeruleus, and commissural nucleus tractus solitarius. Sodium-depen
dent [H-3]naloxone binding sites were not found in other areas that exhibit
ed [H-3]naloxone binding in control tissue, including the striatum and thal
amus. These studies revealed the presence of a subpopulation of [H-3]naloxo
ne binding sites which are sodium-dependent and have a unique regional dist
ribution in the rat brain. (C) 2000 Wiley-Liss, Inc.